Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Additionally we are shipping UBE2L3 Antibodies (113) and UBE2L3 Kits (5) and many more products for this protein.
Showing 8 out of 18 products:
Human UBE2L3 Protein expressed in Human - ABIN2734856
Koo, Chae, Kim, Kang, Kim, Kwak, Jung, Cho, Choi, Park, Shin, Jang, Shin, Hwang, Yi, Park: Identification of novel autoantibodies in type 1 diabetic patients using a high-density protein microarray. in Diabetes 2014
The TCGGC haplotype is associated with an increased risk of Hashimoto Thyroiditis(HT) and UBE2L3 gene is likely to be a susceptibility factor to HT in a Chinese Han population.
together with UBE2N (show UBE2N Proteins) and UBE2D2 (show UBE2D2 Proteins), synergistically contribute to Parkin (show PARK2 Proteins)-mediated mitophagy
The MAP1B-LC1 could interact with the ubiquitin-conjugating E2 enzyme UBE2L3 and that the ubiquitination/degradation mechanism triggered by MAP1B-LC1 could be prevented by inhibiting the ubiquitin-proteasome proteolytic pathway.
An interaction between LC1 and the ubiquitin-conjugating enzyme (show Ube2t Proteins) UBE2L3.
UbcH7 has a role in regulating 53BP1 (show TP53BP1 Proteins) stability and DSB repair
UBE2L3 polymorphism amplifies NF-kappaB (show NFKB1 Proteins) activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases.
Report role of UBE2L3 genetic variants in confering risk of systemic lupus erythematosus in Chinese population.
Importance of HLA-C and UBE2L3 in the clearance of HBV infection in addition to HLA-DP (show HLA-DPB1 Proteins) and HLA-DQ.
The results suggest that variants carried on the SLE-associated UBE2L3 risk haplotype influence autoimmunity by modulating UBCH7 expression.
UBE2L3 was found to be a shared susceptibility gene for siffuse cutaneous systemic sclerosis in a Japanese population.
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene.
ubiquitin-conjugating enzyme E2L 3
, ubiquitin-conjugating enzyme E2 L3
, ubiquitin carrier protein L3
, ubiquitin-protein ligase L3
, ubiquitin-conjugating enzyme E2-F1
, ubiquitin-conjugating enzyme UBCH7
, ubiquitin-conjugating enzyme 7
, ubiquitin-conjugating enzyme E2L 3, like